English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 32 Help

Selected(0)Clear Items/Page:    Sort:
Berberine and magnolol exert cooperative effects on ulcerative colitis in mice by self-assembling into carrier-free nanostructures Journal article
Xu, Yida, Chen, Zhejie, Hao, Wei, Yang, Zhengming, Farag, Mohamed, Vong, Chi Teng, Wang, Yitao, Wang, Shengpeng. Berberine and magnolol exert cooperative effects on ulcerative colitis in mice by self-assembling into carrier-free nanostructures[J]. Journal of Nanobiotechnology, 2024, 22(1), 538.
Authors:  Xu, Yida;  Chen, Zhejie;  Hao, Wei;  Yang, Zhengming;  Farag, Mohamed; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:10.6/11.4 | Submit date：2024/10/10
Berberine  Gut Microbiota  Magnolol  Self-assembly  Ulcerative Colitis  
Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis Journal article
Chen, Shiyun, Chen, Zhejie, Wang, Yi, Hao, Wei, Yuan, Qin, Zhou, Hefeng, Gao, Caifang, Wang, Yitao, Wu, Xu, Wang, Shengpeng. Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis[J]. Journal of Advanced Research, 2022, 40, 263-276.
Authors:  Chen, Shiyun;  Chen, Zhejie;  Wang, Yi;  Hao, Wei;  Yuan, Qin; et al.
Favorite | TC[WOS]:37 TC[Scopus]:37  IF:11.4/11.0 | Submit date：2022/05/13
Berberine  Drug Delivery  Gut Microbiome  Tannin Acid  Ulcerative Colitis  
Berberine remodels adipose tissue to attenuate metabolic disorders by activating sirtuin 3 Journal article
Li, Dan, Yang, Chao, Zhu, Jian zhong, Lopez, Eduardo, Zhang, Tian, Tong, Qiang, Peng, Cheng, Lin, Li gen. Berberine remodels adipose tissue to attenuate metabolic disorders by activating sirtuin 3[J]. ACTA PHARMACOLOGICA SINICA, 2022, 43(5), 1285-1298.
Authors:  Li, Dan;  Yang, Chao;  Zhu, Jian zhong;  Lopez, Eduardo;  Zhang, Tian; et al.
Favorite | TC[WOS]:38 TC[Scopus]:42  IF:6.9/7.6 | Submit date：2022/05/13
Adipose Tissue Inflammation  Berberine  Fibrosis  Insulin Resistance  Liver Injury  Sirtuin 3  
The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics Journal article
Yu, Qiuxia, Li, Minhua, Chen, Hanbin, Xu, Lieqiang, Cheng, Juanjuan, Lin, Guoshu, Liu, Yuhong, Su, Ziren, Yang, Xiaobo, Li, Yucui, Chen, Jiannan, Xie, Jianhui. The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics[J]. DRUG DELIVERY, 2022, 29(1), 856-870.
Authors:  Yu, Qiuxia;  Li, Minhua;  Chen, Hanbin;  Xu, Lieqiang;  Cheng, Juanjuan; et al.
Favorite | TC[WOS]:15 TC[Scopus]:15  IF:6.5/6.7 | Submit date：2022/05/17
Berberine  Erythrocyte  Hemoglobin  Pharmacokinetics  Self-assembly System  
Improved up-and-down procedure for acute toxicity measurement with reliable LD50 verified by typical toxic alkaloids and modified Karber method Journal article
Zhang, Yan Yu, Huang, Yu Feng, Liang, Jie, Zhou, Hua. Improved up-and-down procedure for acute toxicity measurement with reliable LD50 verified by typical toxic alkaloids and modified Karber method[J]. BMC Pharmacology and Toxicology, 2022, 23(1).
Authors:  Zhang, Yan Yu;  Huang, Yu Feng;  Liang, Jie;  Zhou, Hua
Favorite | TC[WOS]:25 TC[Scopus]:26 | Submit date：2023/01/30
Acute Toxicity  Berberine Hydrochloride  Improved Up-and-down Procedure  Median Lethal Dose  Modified Karber Method  Nicotine  Sinomenine Hydrochloride  
Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs Journal article
Xiong, Wei, Xiong, Shi Hang, Chen, Qi Ling, Linghu, Ke Gang, Zhao, Guan Ding, Chu, John M.T., Wong, Gordon T.C., Li, Juan, Hu, Yuan Jia, Wang, Yi Tao, Yu, Hua. Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs[J]. Carbohydrate Polymers, 2021, 266.
Authors:  Xiong, Wei;  Xiong, Shi Hang;  Chen, Qi Ling;  Linghu, Ke Gang;  Zhao, Guan Ding; et al.
Favorite | TC[WOS]:15 TC[Scopus]:18  IF:10.7/10.2 | Submit date：2021/09/13
Berberine  Brij-grafted-chitosan  Diabetic Kidney Disease  Oral Nanocarrier  P-glycoprotein  
A comparative investigation of the interaction and pharmacokinetics of hemoglobin with berberine and its oxymetabolite Journal article
Chen, Han Bin, Luo, Chao Dan, Ai, Gao Xiang, Wang, Yong Fu, Li, Cai Lan, Tan, Li Hua, Lee, Simon Ming Yuen, Cheung, Alex Kwok Kuen, Su, Zi Ren, Wu, Xiao Li, Xie, Jian Hui, Zeng, Hui Fang. A comparative investigation of the interaction and pharmacokinetics of hemoglobin with berberine and its oxymetabolite[J]. Journal of Pharmaceutical and Biomedical Analysis, 2021, 199, 114032.
Authors:  Chen, Han Bin;  Luo, Chao Dan;  Ai, Gao Xiang;  Wang, Yong Fu;  Li, Cai Lan; et al.
Favorite | TC[WOS]:12 TC[Scopus]:14  IF:3.1/3.1 | Submit date：2021/12/07
Berberine  Hemoglobin  Interaction  Metabolite  Pharmacokinetics  
Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats Journal article
Li, Qiao Ping, Dou, Yao Xing, Huang, Zi Wei, Chen, Han Bin, Li, Yu Cui, Chen, Jian Nan, Liu, Yu Hong, Huang, Xiao Qi, Zeng, Hui Fang, Yang, Xiao Bo, Su, Zi Ren, Xie, Jian Hui. Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats[J]. Phytomedicine, 2021, 85, 153550.
Authors:  Li, Qiao Ping;  Dou, Yao Xing;  Huang, Zi Wei;  Chen, Han Bin;  Li, Yu Cui; et al.
Favorite | TC[WOS]:34 TC[Scopus]:36  IF:6.7/6.2 | Submit date：2021/12/07
Ampk Signaling Pathway  Berberine  Insulin Signaling Pathway  Non-alcoholic Fatty Liver Disease  Obesity  Oxyberberine  
Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways Journal article
Dou, Yaoxing, Huang, Ronglei, Li, Qiaoping, Liu, Yuhong, Li, Yucui, Chen, Hanbin, Ai, Gaoxiang, Xie, Jianhui, Zeng, Huifang, Chen, Jiannan, Luo, Chaodan, Su, Ziren. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways[J]. Biomedicine and Pharmacotherapy, 2021, 137, 111312.
Authors:  Dou, Yaoxing;  Huang, Ronglei;  Li, Qiaoping;  Liu, Yuhong;  Li, Yucui; et al.
Favorite | TC[WOS]:56 TC[Scopus]:58  IF:6.9/6.8 | Submit date：2021/12/08
Berberine  Diabetes  Metabolite  Oxidative Stress And Inflammation  Oxyberberine  
Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies Review article
2021
Authors:  Yang,Yuhan;  Vong,Chi Teng;  Zeng,Shan;  Gao,Caifang;  Chen,Zhejie; et al.
Favorite | TC[WOS]:27 TC[Scopus]:29  IF:4.8/4.8 | Submit date：2021/03/02
Berberine  Clinical Study  Coptis Chinensis  Inflammatory Bowel Disease  Pharmacokinetics  Pharmacology  Review